SOPHiA GENETICS (SOPH) Stock Statistics & Valuation Metrics

SOPHiA GENETICS has a market cap or net worth of $330.39M. The enterprise value is $323.12M.

SOPHiA GENETICS has 71,668,700 shares outstanding. The number of shares has decreased by -2.65% in one year.

SOPHiA GENETICS’s return on equity (ROE) is -1.68 and return on invested capital (ROIC) is -61.34%.

The current PE Ratio of SOPHiA GENETICS is ―. SOPHiA GENETICS’s PEG ratio is -0.17.

In the last 12 months, SOPHiA GENETICS had revenue of 77.27M and earned -79.00M in profits. Earnings per share was -1.17.

In the last 12 months, operating cash flow was -36.69M and capital expenditures -3.92M, giving a free cash flow of -40.61M billion.

SOPHiA GENETICS pays an annual dividend of ―, resulting in a dividend yield of ―

SOPHiA GENETICS upcoming earnings date is May 12, 2026, Before Open (Confirmed).

SOPHiA GENETICS as a current ratio of 1.96, with Debt / Equity ratio of 133.67%

In the past 12 months, SOPHiA GENETICS has paid 512.00K in taxes.

SOPHiA GENETICS EV to EBITDA ratio is -5.02, with an EV/FCF ratio of -7.99.

SOPHiA GENETICS has $70.29M in cash and marketable securities with $63.02M in debt, giving a net cash position of $7.27M billion.

Gross margin is 67.40%, with operating margin of -91.79%, and net profit margin of -102.24%.

The average price target for SOPHiA GENETICS is $7.00, which is 11.43% higher than the current price. The consensus rating is Strong Buy